O-serogroups, eae gene and EAF plasmid in Escherichia coli isolates from cases of bovine mastitis in Brazil

Mastitis has been recognized for some time as the most costly disease in dairy herds. From March 1997 to August 1998. 2144 samples of bovine mastitic milk were collected, from which 182 Escherichia coli isolates were made, and from which 14 1 isolates had the somatic anti-en (serogroup) determined. Twelve different serogroups were isolated from mastitic milk, and among them were 026, 055, 0111 and 0 119, all of them classic enteropathogenic E. (oh (EPEC) serogroups. These represented 40.0% of the isolates. The 20 of 57 isolates tested had plasmids and in dot blot hybridization, nine isolates were positive for an EaeA probe and an EPEC adherence factor (EAF) probe while two isolates were negative for EaeA probe but positive for the EAF probe, the nine isolates were characterized as attaching and effacing (A/E) E, coli (AEEC) isolates. (C) 2002 Elsevier B.V. B.V. All rights reserved.

Persistent inflammation in the CNS during chronic EAE despite local absence of IL-17 production

Experimental autoimmune encephalomyelitis (EAE) is an artificially induced demyelination of the central nervous system (CNS) that resembles multiple sclerosis in its clinical, histopathological, and immunological features. Activated Th1 and Th17 cells are thought to be the main immunological players during EAE development. This study was designed to evaluate peripheral and local contribution of IL-17 to acute and chronic EAE stages. C57BL/6 mice were immunized with MOG plus complete Freund's adjuvant followed by pertussis toxin. Mice presented an initial acute phase characterized by accentuated weight loss and high clinical score, followed by a partial recovery when the animals reached normal body weight and smaller clinical scores. Spleen cells stimulated with MOG produced significantly higher levels of IFN-γ during the acute period whereas similar IL-17 levels were produced during both disease stages. CNS-infiltrating cells stimulated with MOG produced similar amounts of IFN-γ but, IL-17 was produced only at the acute phase of EAE. The percentage of Foxp3+ Treg cells, at the spleen and CNS, was elevated during both phases. The degree of inflammation was similar at both disease stages. Partial clinical recovery observed during chronic EAE was associated with no IL-17 production and presence of Foxp3+ Treg cells in the CNS. © 2013 Sofia Fernanda Gonçalves Zorzella-Pezavento et al.

Efeito modulador de estratégias vacinais para tuberculose na encefalite autoimune experimental (EAE)

Pós-graduação em Doenças Tropicais - FMB

Avaliação dos padrões de susceptibilidade antimicrobianas e sorogrupos de cepas de Escherichia coli isoladas de bovinos leiteiros, portadoras e não portadoras dos genes stx1, stx2 e eae

Pós-graduação em Microbiologia Agropecuária - FCAV

Downmodulation of peripheral MUG-specific immunity by pVAXhspe65 treatment during EAE does not reach the CNS

Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP)

Efeito modulador da estratégia vacinal BCG/DNAhsp65 na encefalite autoimune experimental(EAE)

Tanto o BCG (Bacilo de Calmette-Guérin) quanto a DNAhsp65 são vacinas contra tuberculose, porém além da atividade protetora desejável ambas apresentam atividade imunomoduladora. Seguindo a linha de pesquisa de nosso laboratório que investiga a atividade da DNAhsp65 sobre doenças autoimunes, avaliamos o efeito da associação destas vacinas sob a forma de uma estratégia vacinal tipo prime-boost (priming com BCG seguida de booster com DNAhsp65), sobre o desenvolvimento da Encefalite Autoimune Experimental (EAE), que é modelo animal de esclerose múltipla. Ratos Lewis fêmeas foram divididos em grupos de 5 a 6 animais (salina, BCG, EAE, BCG/EAE, BCG/vetor/EAE e BCG/vacina/EAE) e imunizados em intervalos de 15 dias. Os animais receberam um primming com 2 - 10 x 105 unidades formadoras de colônias de BCG subcutâneo seguido de dois boosters com 300 g de pVAXhsp65 numa solução de sacarose 25% por via intramuscular. A EAE foi induzida 15 dias após a última imunização, por inoculação de 25 g de proteína básica de mielina (MBP) associada ao Adjuvante Completo de Freund contendo Mycobacterium butyricum. Aqueles que não receberam os inóculos descritos foram injetados com salina, exceto o grupo BCG/vetor/EAE que recebeu 300 g de pVAX (vetor plasmidial vazio) também em solução de sacarose. Os animais foram acompanhados diariamente até serem submetidos à eutanásia, 3 semanas mais tarde, durante a fase de recuperação da doença para avaliação da resposta imune, escore clínico e presença de infiltrado inflamatório no SNC. A evolução clínica da EAE foi similar entre animais vacinados e não vacinados, mas a análise histopatológica revelou que a imunização prévia com BCG ou BCG/DNAhsp65 diminui o processo inflamatório. No cérebro foi observada redução acentuada do processo inflamatório nos grupos BCG/EAE, ...(Resumo completo, clicar acesso eletrônico abaixo)

Human Endometrial-Derived Mesenchymal Stem Cells Suppress Inflammation in the Central Nervous System of EAE Mice

FAPESP [2009/13109-5]

Inhibierung des IL-17A vermittelten Blut-Hirnschrankenversagens in experimenteller Autoimmunenzephalomyelitis (EAE) und Mikrogliaaktivierung durch IL-17A

Experimentelle Autoimmunenzephalomyelitis (EAE) ist das Tiermodell für Multiple Sklerose (MS). Es ist bekannt, dass das proinflammatorische Zytokin IL-17A eine wichtige Rolle in MS und EAE spielt. Dieses wird hauptsächlich von einer Subpopulation der T-Helferzellen (Th17 Zellen) exprimiert. Es war bekannt, dass diese am Zusammenbruch der Blut-Hirnschranke (BHS) beteiligt sind. Der Integritätsverlust der BHS ist ein wichtiger und früher Aspekt in der Pathogenese von EAE und MS. Daraufhin können Immunzellen in das zentrale Nervensystem (ZNS) eindringen. Spezifische T-Zellen greifen das Myelin an und führen so zu einer Entzündungsreaktion, Demyelinisierung und axonalem Schaden. In dieser Arbeit konnte ich zeigen, dass durch Hemmung des kontraktilen endothelialen Apparates das BHS Versagen vermindert werden kann und es dadurch zu einem milderen Verlauf der EAE Pathogenese kommt. Wird der Inhibitor der Myosinleichtkettenkinase ML-7 C57/bl6 Mäusen, bei denen EAE induziert wurde, intraperitoneal verabreicht, kommt es zu einem geringeren Phosphorylierungsgrad der leichten Kette des Myosins in Endothelzellen und folglich zu einem verringerten Schrankenversagen. Außerdem konnte ich zeigen, dass weniger reaktive Sauerstoffspezies (ROS) gebildet werden. Folglich kommt es zu einer geringeren Infiltration von Immunzellen aus der Peripherie in das ZNS. Somit werden weniger Zytokine und auch Matrixmetalloproteinasen (MMP) ausgeschüttet, wodurch die Entzündungsreaktion weniger stark ausgeprägt ist. Außerdem werden weniger Mikrogliazellen aktiviert. Ich habe den Zusammenhang zwischen Mikrogliazellaktivierung und IL-17A näher untersucht. Dieses proinflammatorische Zytokin aktiviert Mikrogliazellen auch in vitro. Durch IL-17A Stimulation kommt es zur vermehrten ROS Bildung. Folglich kommt es zu einer vermehrten Proliferation und Migration, sowie einer erhöhten Zytokinproduktion. Außerdem konnte ich zeigen, dass der N-Methyl-D-Aspartat (NMDA)-Rezeptor an der Mikrogliaaktivierung beteiligt ist. Abhängig von IL-17A Stimulation kommt es zu einem Kalziumeinstrom über den NMDA-Rezeptor. Werden Inhibitoren des NMDA-Rezeptors eingesetzt, können IL-17A vermittelte Proliferation, Migration, Zytokin-und ROS-Produktion verhindert werden. Der NMDA-Rezeptor ist sehr gut in Neuronen erforscht, wohingegen bisher sehr wenig über seine Funktion in Gliazellen bekannt war. In dieser Arbeit ist es mir gelungen einen Zusammenhang zwischen IL-17A vermittelter Mikrogliaaktivierung und Kalziumeinstrom über den NMDA-Rezeptor herzustellen.

IL-6 transsignalling modulates the early effector phase of EAE and targets the blood-brain barrier

Interleukin-6 (IL-6) plays a crucial role in the pathogenesis of experimental autoimmune encephalomyelitis (EAE). It exerts its cellular effects by a membrane-bound IL-6 receptor (IL-6R), or, alternatively, by forming a complex with the soluble IL-6R (sIL-6R), a process named IL-6 transsignalling. Here we investigate the role of IL-6 transsignalling in myelin basic protein (MBP)-induced EAE in the Lewis rat. In vivo blockade of IL-6 transsignalling by the injection of a specifically designed gp130-Fc fusion protein significantly delayed the onset of adoptively transferred EAE in comparison to control rats injected with PBS or isotype IgG. Histological evaluation on day 3 after immunization revealed reduced numbers of T cells and macrophages in the lumbar spinal cord of gp130-Fc treated rats. At the same time, blockade of IL-6 transsignalling resulted in a reduced expression of vascular cell adhesion molecule-1 on spinal cord microvessels while experiments in cell culture failed to show a direct effect on the regulation of endothelial adhesion molecules. In experiments including active EAE and T cell culture, inhibition of IL-6 transsignalling mildly increased T cell proliferation, but did not change severity of active MBP-EAE or regulate Th1/Th17 responses. We conclude that IL-6 transsignalling may play a role in autoimmune inflammation of the CNS mainly by regulating early expression of adhesion molecules, possibly via cellular networks at the blood-brain barrier.

C-C chemokine receptor 6-regulated entry of TH-17 cells into the CNS through the choroid plexus is required for the initiation of EAE

Interleukin 17-producing T helper cells (T(H)-17 cells) are important in experimental autoimmune encephalomyelitis, but their route of entry into the central nervous system (CNS) and their contribution relative to that of other effector T cells remain to be determined. Here we found that mice lacking CCR6, a chemokine receptor characteristic of T(H)-17 cells, developed T(H)-17 responses but were highly resistant to the induction of experimental autoimmune encephalomyelitis. Disease susceptibility was reconstituted by transfer of wild-type T cells that entered into the CNS before disease onset and triggered massive CCR6-independent recruitment of effector T cells across activated parenchymal vessels. The CCR6 ligand CCL20 was constitutively expressed in epithelial cells of choroid plexus in mice and humans. Our results identify distinct molecular requirements and ports of lymphocyte entry into uninflamed versus inflamed CNS and suggest that the CCR6-CCL20 axis in the choroid plexus controls immune surveillance of the CNS.

PSGL-1 and E/P-selectins are essential for T-cell rolling in inflamed CNS microvessels but dispensable for initiation of EAE

T-cell migration across the blood-brain barrier is a crucial step in the pathogenesis of EAE, an animal model for MS. Live cell imaging studies demonstrated that P-selectin glycoprotein ligand-1 (PSGL-1) and its endothelial ligands E- and P-selectin mediate the initial rolling of T cells in brain vessels during EAE. As functional absence of PSGL-1 or E/P-selectins does not result in ameliorated EAE, we speculated that T-cell entry into the spinal cord is independent of PSGL-1 and E/P-selectin. Performing intravital microscopy, we observed the interaction of WT or PSGL-1(-/-) proteolipid protein-specific T cells in inflamed spinal cord microvessels of WT or E/P-selectin(-/-) SJL/J mice during EAE. T-cell rolling but not T-cell capture was completely abrogated in the absence of either PSGL-1 or E- and P-selectin, resulting in a significantly reduced number of T cells able to firmly adhere in the inflamed spinal cord microvessels, but did not lead to reduced T-cell invasion into the CNS parenchyma. Thus, PSGL-1 interaction with E/P-selectin is essential for T-cell rolling in inflamed spinal cord microvessels during EAE. Taken together with previous observations, our findings show that T-cell rolling is not required for successful T-cell entry into the CNS and initiation of EAE.

Estudio crítico comparativo de las metodologías de análisis de la rigidización de fondos comprimidos y almas de puentes mixtos planteadas por las diferentes normativas : RPX-95, EAE y EC4

Los puentes con sección mixta de hormigon y acero son, a dia de hoy, una de las tipologias mas recurrentes por las diversas, y ya conocidas, ventajas que ofrecen en determinadas circunstancias. Resulta por tanto necesario, y de interes, estar actualizado y conocer el marco normativo que rige el diseño y proyecto de este tipo de puentes. El planteamiento normativo referente al desarrollo de proyectos de puentes mixtos se encuentra actualmente en una fase de transicion durante la cual se llevaria a cabo la redaccion de una nueva “Instruccion para el Proyecto de Puentes Mixtos”, la cual incorporaria directamente las prescripciones del Eurocodigo 4. Dicha instruccion sustituira a las actualmente vigentes “Recomendaciones para el Proyecto de Puentes Mixtos para Carretera (RPX-95)”. Por otra parte, en el ano 2011, se incorpora a la reglamentacion la “Instruccion de Acero Estructural (EAE)” en la cual se establecen criterios de ambito comun con los dos documentos anteriormente citados. La coyuntura normativa descrita en el parrafo anterior hace que resulte de gran interes realizar un estudio comparativo entre las normativas actualmente vigentes: - Eurocodigo 4: “Proyecto de estructuras mixtas de acero y hormigon”-RPX-95: “Recomendaciones para el Proyecto de Puentes Mixtos para Carretera”-EAE: “Instruccion de Acero Estructural”. Uno de los principales objetivos de este estudio es poder extraer conclusiones interesantes de cara a la implementacion definitiva de los Eurocodigos en el marco normativo espanol, hecho que se preve que se produzca en un futuro cercano, alrededor del ano 2018. Dentro de la amplia casuistica que hace referencia al proyecto de puentes mixtos, el presente estudio se centra en las metodologias de analisis referentes a la rigidizacion de fondos comprimidos y almas. Por tanto, se analizaran y compararan los criterios relacionados con los Estados Limites ultimos de piezas flectadas con seccion mixta y se estudiara como influyen los rigidizadores, tanto transversales como longitudinales, en dichos Estados Limites Ultimos. Concretamente los Estados Limites Ultimos que seran objetivo de estudio seran: Resistencia a Flexion y a Cortante de la seccion, y dimensionado de los Rigidizadores. El estudio de los ELU recientemente citados incluye el analisis de la diversa casuistica tipica de los puentes mixtos: fenomenos de inestabilidad en fondos comprimidos y almas, presencia de losa inferior de hormigon en secciones de momentos negativos, particularidades de la seccion cajon, etc. Se debe resaltar que las diversas normativas de estructuras mixtas de hormigon y acero remiten con asiduidad en varios de sus apartados a las normativas especificas para estos materiales, por ejemplo al Eurocodigo 3 o al EHE. Por lo tanto el estudio de las secciones mixtas comporta tambien un buen conocimiento y dominio de las normativas que hacen referencia al hormigon y al acero por separado. Formalmente, el cuerpo del trabajo se estructura en tres partes bien diferenciadas: -CAPITULO III: Estudio critico comparativo -CAPITULO IV: Aplicacion practica de Eurocodigo y RPX-95 -CAPITULO V: Desarrollo de herramienta de calculo para la verificacion de rigidizadores transversales segun el Eurocodigo 4. En el CAPITULO III se lleva a cabo un analisis comparativo de la metodologia de analisis, condiciones y limitaciones que proponen cada una de las normativas, destacando las semejanzas y diferencias existentes entre ellas. Este apartado es basicamente teorico y tiene como objetivo observar las diferencias principales que existen y discutir el porque de estas, para los diversos criterios de Estado Limite Ultimo estudiados. Un aspecto interesante desde el punto de vista practico del diseño y proyecto de puentes es observar si las normativas son mas o menos conservadoras en las verificaciones que proponen y las limitaciones que establecen, ya que esto afecta directamente al coste del puente. A continuacion, en el CAPITULO IV, se realiza una aplicacion practica de algunos de los aspectos de Estado Limite ultimo estudiados en el CAPITULO III. Se aplican las metodologias de las dos normativas estudiadas con mayor profundidad, Eurocodigo y RPX-95, a diversas secciones tipo. De esta manera, se podran complementar y corroborar con datos numericos, las conclusiones extraidas del analisis comparativo del capitulo anterior. Por ultimo, en el CAPITULO V, se expone de manera detallada la informacion acerca de la hoja de Excel en que se ha implementado la metodologia de calculo para la verificacion de rigidizadores transversales segun los Eurocodigos. Esta hoja de calculo tiene como objetivo ser la version actualizada de ACE-003-Comprobación rigidizadores en cajones y perfiles en "H", una hoja de calculo utilizada e implementada en MC2 Estudio de Ingeniería S.L. en base a las directrices dictadas por la “Recomendaciones para el Proyecto de Puentes Mixtos para Carretera”.

CD8+ T cells control the TH phenotype of MBP-reactive CD4+ T cells in EAE mice

Trimolecular interactions between the T cell antigen receptor and MHC/peptide complexes, together with costimulatory molecules and cytokines, control the initial activation of naïve T cells and determine whether the helper precursor cell differentiates into either T helper (TH)1 or TH2 effector cells. We now present evidence that regulatory CD8+ T cells provide another level of control of TH phenotype during further evolution of immune responses. These regulatory CD8+ T cells are induced by antigen-triggered CD4+ TH1 cells during T cell vaccination and, in vitro, distinguish mature TH1 from TH2 cells in a T cell antigen receptor Vβ-specific and Qa-1-restricted manner. In vivo, protection from experimental autoimmune encephalomyelitis (EAE) induced by T cell vaccination depends on CD8+ T cells, and myelin basic protein-reactive TH1 Vβ8+ clones, but not TH2 Vβ8+ clones, used as vaccine T cells, protect animals from subsequent induction of EAE. Moreover, in vivo depletion of CD8+ T cells during the first episode of EAE results in skewing of the TH phenotype toward TH1 upon secondary myelin basic protein stimulation. These data provide evidence that CD8+ T cells control autoimmune responses, in part, by regulating the TH phenotype of self-reactive CD4+ T cells.